To investigate the efficacy and safety of PARIET twice daily (b.i.d.) in patients with Proton Pump Inhibitor-resistant reflux esophagitis
Study Type
OBSERVATIONAL
Enrollment
2,157
Doses of 10 mg or 20 mg twice daily may be administered orally to reflux esophagitis patients for a further 8 weeks when proton pump inhibitor treatment is ineffective. However, a dose of 20 mg twice daily should only be administered to patients with severe mucosa injury.
Number of subjects with improvement based on health related Quality of Life (QOL) questionnaire
Time frame: Check at predose, 4, 8, 16 and 32 weeks
Number of subjects with improvement in symptoms of GERD
Time frame: Check at predose, 4, 8, 16 and 32 weeks
Endoscopic healing rate
Time frame: 8 weeks
Adverse events
Time frame: Every 4-8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Aisai, Aichi-ken, Japan
Unnamed facility
Anjo, Aichi-ken, Japan
Unnamed facility
Gamagōri, Aichi-ken, Japan
Unnamed facility
Ichinomiya, Aichi-ken, Japan
Unnamed facility
Inuyama, Aichi-ken, Japan
Unnamed facility
Kariya, Aichi-ken, Japan
Unnamed facility
Kasugai, Aichi-ken, Japan
Unnamed facility
Nagoya, Aichi-ken, Japan
Unnamed facility
Okazaki, Aichi-ken, Japan
Unnamed facility
Owariasahi, Aichi-ken, Japan
...and 437 more locations